Coronary Heart Disease [antikvár]

Foreword Foreword Coronary heart disease is the primary cause of morbidity and mortality in the civilised world. It is estimated that in the industrialised countries up to a quarter of all deaths are directly or indirectly attributable to it. Even if the increase in incidence of coronary heart disease and its sequelae appear dramatic, it is, however, a disease which should not simply be accepted by the patient. In the first place, there are many ways of protecting oneself against it and, secondly, nowadays the disease can be diagnosed at such an early stage and so reliably that a treatment strategy tailored specifically to the requirements of the individual patient can considerably improve his prognosis. In order to avoid the risk factors and to identify coronary heart disease at an early stage, it is not just the patient himself who must be well informed, but also the general practitioner and the pharmacist. This publication provides extensive information on coronary heart disease and the possibilities now available for prevention, diagnosis and therapy. The success story of Aspirin® began nearly one hundred years ago when it was used for the treatment of pain, fever and inflammatory diseases, such as rheumatism. As a result of the progress made in medical science and drug technology, the compound originally developed in Bayer AG laboratories in 1897 as a remedy against headaches and rheumatism now has a wide range of application, especially in the prevention and treatment of cardiovascular diseases, and is therefore employed in both